National Academy of Sciences | 150 Year Anniversary

Questions? Call 800-624-6242

| Items in cart [0]

The National Academies Press

PAPERBACK
price:$55.00
add to cart

Rights & Permissions

topleft topright

Human Biomonitoring for Environmental Chemicals (2006)
Board on Environmental Studies and Toxicology (BEST)

Citation Manager

. "4 Considerations in the Design of Biomonitoring Studies." Human Biomonitoring for Environmental Chemicals. Washington, DC: The National Academies Press, 2006.

Please select a format:

BibTeX EndNote RefMan


Page
131
bottomleft bottomright

The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy.


Human Biomonitoring for Environmental Chemicals

Schulte, P.A., and M.H. Sweeney. 1995. Ethical considerations, confidentiality issues, rights of human subjects, and uses of monitoring data in research and regulation. Environ. Health Perspect. 103(suppl. 3):69-74.

Schulte, P.A., and G. Talaska. 1995. Validity criteria for the use of biological markers of exposure to chemical agents in environmental epidemiology. Toxicology 101(1-2): 73-88.

Schulte, P.A., D. Hunter, and N. Rothman. 1997. Ethical and social issues in the use of biomarkers in epidemiological research. IARC Sci Publ. (142):313-318.

Silva, M.J., D.B. Barr, J.A. Reidy, N.A. Malek, C.C. Hodge, S.P. Caudill, J.W. Brock, L.L. Needham, and A.M. Calafat. 2004. Urinary levels of seven phthalate metabolites in the U.S. population from the National Health and Nutrition Examination Study (NHANES) 1999-2000. Environ. Health Perspect. 112(3): 331-338.

Soskolne, C.L. 1997. Ethical, social, and legal issues surrounding studies of susceptible populations and individuals. Environ. Health Perspect. 105(suppl. 4):837-841.

Stern, P.C., and H.V. Fineberg, eds. 1996. Understanding Risk: Informing Decisions in a Democratic Society. Washington, DC: National Academy Press.

Stinson, B.L., and J.R. Ehrmann. 1998. Joint fact-finding in consensus-building processes. Inside EPA’s-Risk Policy Report 5(11):36-38.

Thompson, K.M., and D.L. Bloom. 2000. Communication of risk assessment information to risk managers. J. Risk Res. 3(4):333-352.

Tinker, T. 1994. Case Studies of Applied Evaluation for Health Risk Communication: Workshop Proceedings, June 9, Annapolis, MD. U.S. Department of Health and Human Services, Washington, DC.

Veach, P.M., D.M. Bartels, and B.S. LeRoy. 2001. Ethical and professional challenges posed by patients with genetic concerns: A report of focus group discussions with genetic counselors, physicians, and nurses. J. Genet. Couns. 10(2):97-119.

Warholm, M., A.K. Alexandrie, J. Hogberg, K. Sigvardsson, A. Rannug. 1994. Polymorphic distribution or glutathione transferase activity with methyl chloride in human blood. Pharmacogenetics 4(6):307-311.

Webler, T. 1998. Beyond science: Deliberation and analysis in public decision making. Human Ecol. Rev. 5(1):61-64.

Weinstein, N.D., and P.M. Sandman. 1993. Some criteria for evaluating risk messages. Risk Anal. 13(1):103-114.

Wessels, D., D.B. Barr, and P. Mendola. 2003. Use of biomarkers to indicate exposure of children to organophosphate pesticides: Implications for a longitudinal study of children’s environmental health. Environ. Health Perspect. 111(16):1939-1946.

Winn, D.M., M.E. Reichman, and E. Gunter. 1990. Epidemiologic issues in the design and use of biologic specimen banks. Epidemiol. Rev. 12:56-70.

Page
131